Measure Title/Description ACC/AHA Stage 2 HBP ACC/AHA Stage 1 HBP ACC/AHA Elevated BP COR/LOE Performance Measures* PM-1a ACC/AHA stage 2 HBP control SBP <140 mmHg + - - COR: 1, LOE: A PM-1b ACC/AHA stage 2 HBP control SBP <130 mmHg + - - COR: 1, LOE: A / COR: 2a, LOE: C-EO PM-2 ACC/AHA stage 1 HBP control SBP <130 mmHg - + - COR: 1, LOE: A PM-3 ACC/AHA stage 2 and stage 1 HBP control SBP <130 mmHg (composite measure combining PM- + + - COR: 1, LOE: A / COR: 2a, LOE: C-EO PM-4 Nonpharmacological interventions for ACC/AHA stage 2 HBP + - - COR: 1, LOE: A PM-5 Use of HBPM for management of ACC/AHA stage + - - COR: 1, LOE: A Process Quality Measures* QM-1 Nonpharmacological interventions for ACC/AHA stage elevated BP - - + COR: 1, LOE: A QM-2 Nonpharmacological interventions for ACC/AHA stage 1 HBP - + - COR: 1, LOE: A QM-3 Nonpharmacological interventions for all ACC/AHA stages of HBP (composite measure + + + COR: 1, LOE: A QM-4 Medication adherence to drug therapy for ACC/ AHA stage 1 with ASCVD risk 10% or ACC/AHA stage 2 HBP + + - COR: 1, LOE: A QM-5 Use of HBPM for management of ACC/AHA stage - + - COR: 1, LOE: A QM-6 Use of HBPM for management of ACC/AHA stage 1 or ACC/AHA stage 2 (composite measure + + - COR: 1, LOE: A *Performance measures are used in national quality payment and reporting programs, whereas process quality measures support quality improvement initiatives and activities at the national or microsystem levels. +Indicates the corresponding ACC/AHA stage for the measure. -Indicates that the ACC/AHA stage does not correspond to the measure. 